Table 2.
Cost-effectiveness Analysis of Various Methods of Candida auris Screening: Estimated Laboratory Cost in US Dollars per Case Detected
| Percentage Positivity, US $ | |||||
|---|---|---|---|---|---|
| Detection Method | 0.1 | 0.5 | 1.0 | 5.0 | 10.0 |
| Chromogenic agar culture | 9430.00 | 1886.00 | 943.00 | 188.60 | 94.30 |
| Direct PCR | 11 270.00 | 2254.00 | 1127.00 | 225.40 | 112.70 |
| Enrichment broth followed by | |||||
| Chromogenic agar culture | 29 700.00 | 5940.00 | 2970.00 | 594.00 | 297.00 |
| PCR | 31 540.00 | 6308.00 | 3154.00 | 630.80 | 315.40 |
Cost-effectiveness analysis based on a cost per test that included laboratory consumables (reagents) and medical laboratory technologist time. Equipment cost was not included because costs incurred are dependent on lease or purchase and may vary significantly by laboratory platform used, nor was patient isolation time included as these costs are not borne by the laboratory.
Abbreviation: PCR, polymerase chain reaction.